Interferon Beta-1A: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
|drugClass=immunologic adjuvant
|drugClass=immunologic adjuvant
|indicationType=treatment
|indicationType=treatment
|indication=multiple sclerosis.
|indication=multiple sclerosis
|adverseReactions= flu-like symptoms including chills, [[fever]], [[myalgia]], and [[asthenia]].
|adverseReactions=flu-like symptoms including chills, [[fever]], [[myalgia]], and [[asthenia]]
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)

Revision as of 13:48, 21 August 2014

Interferon Beta-1A
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Interferon Beta-1A is an immunologic adjuvant that is FDA approved for the treatment of multiple sclerosis. Common adverse reactions include flu-like symptoms including chills, fever, myalgia, and asthenia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Interferon Beta-1A FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Interferon Beta-1A in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Interferon Beta-1A in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Interferon Beta-1A FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Interferon Beta-1A in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Interferon Beta-1A in pediatric patients.

Contraindications

There is limited information regarding Interferon Beta-1A Contraindications in the drug label.

Warnings

There is limited information regarding Interferon Beta-1A Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Interferon Beta-1A Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Interferon Beta-1A Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Interferon Beta-1A Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Interferon Beta-1A in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Interferon Beta-1A in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Interferon Beta-1A during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Interferon Beta-1A in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Interferon Beta-1A in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Interferon Beta-1A in geriatric settings.

Gender

There is no FDA guidance on the use of Interferon Beta-1A with respect to specific gender populations.

Race

There is no FDA guidance on the use of Interferon Beta-1A with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Interferon Beta-1A in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Interferon Beta-1A in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Interferon Beta-1A in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Interferon Beta-1A in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Interferon Beta-1A Administration in the drug label.

Monitoring

There is limited information regarding Interferon Beta-1A Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Interferon Beta-1A and IV administrations.

Overdosage

There is limited information regarding Interferon Beta-1A overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Interferon Beta-1A Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Interferon Beta-1A Mechanism of Action in the drug label.

Structure

There is limited information regarding Interferon Beta-1A Structure in the drug label.

Pharmacodynamics

There is limited information regarding Interferon Beta-1A Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Interferon Beta-1A Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Interferon Beta-1A Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Interferon Beta-1A Clinical Studies in the drug label.

How Supplied

There is limited information regarding Interferon Beta-1A How Supplied in the drug label.

Storage

There is limited information regarding Interferon Beta-1A Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Interferon Beta-1A |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Interferon Beta-1A |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Interferon Beta-1A Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Interferon Beta-1A interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Interferon Beta-1A Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Interferon Beta-1A Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.